文献速递细菌感染、耐药与抗菌药物艾滋病与性传播感染

荷兰女性口咽部淋球菌常规普遍检测与选择性或偶然检测的比较:回顾性队列研究

Routine universal testing versus selective or incidental testing for oropharyngeal Neisseria gonorrhoeae in women in the Netherlands: a retrospective cohort study.
PubMed 文献 · Lancet Infect Dis · 2021-01-11

该研究利用荷兰2008至2017年所有性病门诊监测数据,比较女性口咽部淋球菌常规普遍检测(诊所年检测率>85%)与选择性检测(5-85%)或偶然检测(<5%)的感染发现情况。结果显示选择性检测可能漏诊约70%的口咽部感染,其中约半数无合并生殖道或肛直肠感染;常规普遍检测是发现多数感染的最佳策略,但成本效果及对耐药的影响仍需未来研究。

要点

  • 选择性检测可能漏诊约70%的女性口咽部淋球菌感染。
  • 约半数口咽部感染无合并生殖道或肛直肠感染。

核心结论

  • 选择性检测可能漏诊超过三分之二的女性口咽部淋球菌感染。
  • 常规普遍检测是发现多数感染的最佳策略,但成本效果及对耐药的影响需未来研究评估。

主要发现

  • 选择性检测估计会漏诊6221例口咽部淋球菌感染中的4363例(70%;95% CI 69-71)。

关键数值与推荐

  • 常规普遍检测定义为诊所年内检测女性比例>85%,选择性检测为5-85%,偶然检测为<5%。

临床怎么用

  • 常规普遍检测能发现大多数口咽部淋球菌感染,包括无合并生殖道或肛直肠感染者。
  • 仅基于独立危险因素(如被通知性病、性工作、合并生殖道或肛直肠淋球菌)指导检测是最低限度的检测策略。

局限性

  • 原文指出未来需研究评估常规检测的成本效果及其对 antimicrobial resistance 的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Women are not routinely tested for oropharyngeal Neisseria gonorrhoeae. At present, selective testing based on sexual behaviour or risk groups is advocated by international guidelines. Many oropharyngeal infections are asymptomatic and thus remain undetected, establishing a reservoir for ongoing transmission. Data on effectiveness of routine testing are scarce, thus we aimed to assess the optimal testing strategy for oropharyngeal N gonorrhoeae in women. METHODS: In this retrospective cohort study, we used surveillance data obtained from all sexually transmitted infection (STI) clinics in the Netherlands between Jan 1, 2008, and Dec 31, 2017. We collected consultation-level data, and individual-level patient data from 2016 onwards, on sociodemographic characteristics, sexual behaviour in the past 6 months, self-reported symptoms, and STI diagnoses. We compared the prevalence of oropharyngeal N gonorrhoeae between women who attended clinics that offered routine universal testing (defined as >85% of women tested per clinic-year) and women who attended clinics that offered selective testing (defined as 5-85% of women tested per clinic-year) or incidental testing (<5% of women tested per clinic-year). We calculated the number of infections missed by selective testing by extrapolating prevalence for the routine universal testing group to that of weighted and unweighted samples of all selectively tested women. We used multivariable generalised estimating equations to identify independent risk factors for oropharyngeal N gonorrhoeae to identify the optimal selective testing strategy. FINDINGS: 554 266 consultations with at least one N gonorrhoeae test were recorded, of which 545 750 consultations (including repeat visits) were included in the analyses. Of 545 750 consultations, routine universal testing was used in 57 359 (10·5%), selective testing in 444 283 (81·4%), and incidental testing in 44 108 (8·1%). The prevalence of oropharyngeal N gonorrhoeae was 1·4% (95% CI 1·3-1·5; 703 of 50 962 consultations) in the routine testing group compared with 1·4% (1·3-1·5; 1858 of 132 276) in the selective testing group (p=0·68) and 2·8% (1·9-3·9; 30 of 1088) in the incidental testing group (p<0·0001). The prevalence of oropharyngeal-only infections was 47·7% (335 of 703 women) in the routine testing group, 53·3% (991 of 1858) in the selective testing group, and 60·0% (18 of 30) in the incidental testing group. Selective testing would have missed an estimated 4363 (70%; 95% CI 69-71) of all 6221 oropharyngeal N gonorrhoeae infections. Independent risk factors for oropharyngeal N gonorrhoeae were being notified for any STI (adjusted odds ratio 2·1, 95% CI 1·5-3·0), reporting sex work (4·0, 2·3-6·7), and having concurrent genital (51·5, 34·1-77·7) or anorectal (2·6, 1·4-4·8) N gonorrhoeae. Selective testing of women notified for any STI, or who reported sex work, would have led to 5418 (27·8%) of 19 455 women being tested and would have identified 119 (55·6%) of 214 oropharyngeal N gonorrhoeae infections. INTERPRETATION: Selective testing potentially misses more than two-thirds of oropharyngeal N gonorrhoeae infections in women, of whom half have oropharyngeal infections without concurrent genital or anorectal infections. Using independent risk factors for oropharyngeal infection to guide testing is a minimal testing strategy. Routine universal testing is the optimum scenario to detect the majority of infections. However, future studies are needed to assess the cost-effectiveness of routine testing and its effect on antimicrobial resistance. FUNDING: Public Health Service South Limburg.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. van Liere GAFS, Dukers-Muijrers NHTM, Kuizenga-Wessel S, et al. Routine universal testing versus selective or incidental testing for oropharyngeal Neisseria gonorrhoeae in women in the Netherlands: a retrospective cohort study. Lancet Infect Dis. 2021. PMID: 33444559. doi:10.1016/S1473-3099(20)30594-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。